Nurix Therapeutics Inc. (NRIX)
Market Open
20 Jul, 17:47
NASDAQ (NMS) NASDAQ (NMS) Primary $
22. 91
-0.21
-0.8893%
$
1.99B Market Cap
- P/E Ratio
- Div Yield
486,236 Volume
-2.91 Eps
$ 23.12
Previous Close 
Want to track NRIX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Nurix Therapeutics Inc. (NRIX) Statistics
Valuation metrics
Market Cap 1.99B
Enterprise value 1.99B
Trailing P/E (ttm) -6.7
Forward P/E -
PEG ratio 0.25
Price/Sales (ttm) 54.5
Price/Book (mrq) 6.38
Enterprise Value/Revenue 54.24
Enterprise Value/EBITDA -6.24
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 780.91K
Average volume (90 days) 1.38M
Price summary
52-Week low 8.2
52-Week high 25.09
Beta -
50-Day moving average 19.98
200-Day moving average 16.79
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -9.28%
Operating margin -9.82%
Operational effectiveness
Return on assets -0.64%
Return on equity -0.76%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.33
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -3.07
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 3.99
Total debt (mrq) -
Total Debt/Equity (mrq) 0.14
Current ratio (mrq) 6.34%
Book value per share (mrq) 3.62
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
